Amarin Corp Plc (AMRN)

[couldbebetter]

HDGabor provides excellent insight. A BO, primarily for the value of
Europe is the only reasonable option at this point. What to do with
the AMRN sales force? If JT were humane maybe with a BP BO some of that
sales force could be absorbed by that BP. The right BP acquirer may be
able to have a better shot at protecting patents in Europe.

The sooner AMRN is acquired by BP the more value they may be able to
extract, especially if they were to have any interest in an authorized
generic for the US. I still believe the right BP would be one interested
in dominating the Omega-3 market. Of course, given our BO valuation
may now be far lower than previously thought, AMRN could be acquired
by a Eurocentric BP with a focus on Diabetes and CVD. Novo Nordisk
may see it as a specialized play that fits in well with their focus.

JT should have sold long, long ago. Now is the time for him to accept
the situation as it is and do what is best for shareholders, employees,
and patients...sell the company or hire someone capable of doing so!